• 1
    Trissl D. Immunology of Entamoeba histolytica in human and animal hosts. Rev Infect Dis 1982; 4(6): 11541184.
  • 2
    Salata RA, Murray HW, Rubin BY & Ravdin JI. The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. Am J Trop Med Hyg 1987; 37(1): 7278.
  • 3
    Denis M & Chadee K. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect Immun 1989; 57(6): 17501756.
  • 4
    Denis M & Chadee K. Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. J Leukoc Biol 1989; 46(3): 270274.
  • 5
    Ghadirian E & Bout DT. In vitro killing of Entamoeba histolytica trophozoites by interferon-gamma-activated mouse macrophages. Immunobiology 1988; 176(4–5): 341353.
  • 6
    Wang W, Keller K & Chadee K. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect Immun 1992; 60(8): 31693174.
  • 7
    Campbell D & Chadee K. Interleukin (IL)-2, IL-4, and tumor necrosis factor-alpha responses during Entamoeba histolytica liver abscess development in gerbils. J Infect Dis 1997; 175(5): 11761183.
  • 8
    Seydel KB, Smith SJ & Stanley SL Jr. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect Immun 2000; 68(1): 400402.
  • 9
    Ivory CP, Keller K & Chadee K. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils. Infect Immun 2006; 74(1): 528536.
  • 10
    Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F & Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984; 117(1): 8191.
  • 11
    Diamond LS, Harlow DR & Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978; 72(4): 431432.
  • 12
    Campos-Rodriguez R, Jarillo-Luna A, Ventura-Juarez J, et al. Interaction of antibodies with Entamoeba histolytica trophozoites from experimental amebic liver abscess: an immunocytochemical study. Parasitol Res 2000; 86(7): 603607.
  • 13
    Ventura-Juarez J, Jarillo-Luna RA, Fuentes-Aguilar E, et al. Human amoebic hepatic abscess: in situ interactions between trophozoites, macrophages, neutrophils and T cells. Parasite Immunol 2003; 25(10): 503511.
  • 14
    Sambrook J, Fritsch EF & Maniatis T. Molecular Cloning: A Laboratory Manual. Ed. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989;8.46.
  • 15
    Eckmann L, Reed SL, Smith JR & Kagnoff MF. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J Clin Invest 1995; 96(3): 12691279.
  • 16
    Seguin R, Mann BJ, Keller K & Chadee K. The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect Immun 1997; 65(7): 25222527.
  • 17
    Sharma M, Bhasin D & Vohra H. Differential induction of immunoregulatory circuits of phagocytic cells by Gal/Gal NAc lectin from pathogenic and nonpathogenic Entamoeba. J Clin Immunol 2008; 28(5): 542557.
  • 18
    Sharma M, Vohra H & Bhasin D. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica: basis of invasive disease. Parasitology 2005; 131(Pt 6): 783796.
  • 19
    Sierra-Puente RE, Campos-Rodriguez R, Jarillo-Luna RA, et al. Expression of immune modulator cytokines in human fulminant amoebic colitis. Parasite Immunol 2009; 31(7): 384391.
  • 20
    Seydel KB, Zhang T & Stanley SL Jr. Neutrophils play a critical role in early resistance to amebic liver abscesses in severe combined immunodeficient mice. Infect Immun 1997; 65(9): 39513953.
  • 21
    Seydel KB, Li E, Swanson PE & Stanley SL Jr. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun 1997; 65(5): 16311639.
  • 22
    Schain DC, Salata RA & Ravdin JI. Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun 1992; 60(5): 21432146.
  • 23
    Ivory CP, Prystajecky M, Jobin C & Chadee K. Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infect Immun 2008; 76(1): 289297.
  • 24
    Colletti LM, Green M, Burdick MD, Kunkel SL & Strieter RM. Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Shock 1998; 10(4): 248257.
  • 25
    Santos SA, Andrade DR & Andrade Junior DR. Rat hepatocyte invasion by Listeria monocytogenes and analysis of TNF-alpha role in apoptosis. Rev Inst Med Trop Sao Paulo 2005; 47(2): 7380.
  • 26
    Zylberberg H, Rimaniol AC, Pol S, et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 1999; 30(2): 185191.
  • 27
    Gutierrez-Ruiz MC, Gomez Quiroz LE, Hernandez E, et al. Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. Isr Med Assoc J 2001; 3(2): 131136.
  • 28
    Blazquez S, Rigothier MC, Huerre M & Guillen N. Initiation of inflammation and cell death during liver abscess formation by Entamoeba histolytica depends on activity of the galactose/N-acetyl-D-galactosamine lectin. Int J Parasitol 2007; 37(3–4): 425433.
  • 29
    Bracha R, Nuchamowitz Y, Leippe M & Mirelman D. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Mol Microbiol 1999; 34(3): 463472.
  • 30
    Nakada-Tsukui K, Saito-Nakano Y, Ali V & Nozaki T. A retromer-like complex is a novel Rab7 effector that is involved in the transport of the virulence factor cysteine protease in the enteric protozoan parasite Entamoeba histolytica. Mol Biol Cell 2005; 16(11): 52945303.
  • 31
    Pacheco J, Shibayama M, Campos R, et al. In vitro and in vivo interaction of Entamoeba histolytica Gal/GalNAc lectin with various target cells: an immunocytochemical analysis. Parasitol Int 2004; 53(1): 3547.
  • 32
    Galván-Moroyoqui JM, Domínguez-Robles M & Meza I. Entamoeba histolytica and enteropathogenic bacteria induce expression of Toll-receptor in human intestinal cell. XVI Seminario sobre Amibiasis and EMBO Workshop. México, Guanajuato, 2009.
  • 33
    De Kossodo S & Grau GE. Role of cytokines and adhesion molecules in malaria immunopathology. Stem Cells 1993; 11(1): 4148.
  • 34
    Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320(24): 15861591.
  • 35
    McGuire W, Hill AV, Allsopp CE, Greenwood BM & Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371(6497): 508510.
  • 36
    Itoh Y, Okanoue T, Ohnishi N, et al. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1999; 94(5): 13321340.
    Direct Link:
  • 37
    Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG & Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999; 163(11): 62366243.
  • 38
    Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178(5): 15411554.
  • 39
    Chisari FV & Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 2960.
  • 40
    Keller CC, Yamo O, Ouma C, et al. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect Immun 2006; 74(9): 52495260.
  • 41
    Lee CW, Bennouna S & Denkers EY. Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect Immun 2006; 74(3): 19161923.
  • 42
    Luty AJ, Perkins DJ, Lell B, et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68(7): 39093915.
  • 43
    Rojas-Dotor S, Rico G, Perez J, et al. Cytokine expression in CD4(+) cells exposed to the monocyte locomotion inhibitory factor produced by Entamoeba histolytica. Parasitol Res 2006; 98(5): 493495.
  • 44
    Bansal D, Sehgal R, Chawla Y, Malla N & Mahajan RC. Cytokine mRNA expressions in symptomatic vs. asymptomatic amoebiasis patients. Parasite Immunol 2005; 27(1–2): 3743.
  • 45
    Bhattacharjee S, Gupta G, Bhattacharya P, Adhikari A, Majumdar SB & Majumdar S. Anti-IL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. Indian J Exp Biol 2009; 47(6): 489497.
  • 46
    Silva JS, Twardzik DR & Reed SG. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 1991; 174(3): 539545.